Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax®) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip®) to adults aged ≥60 years: An open-label, randomised trial
Zimmermann, Ulrich, Gavazzi, Gaëtan, Richard, Patrick, Eymin, Cécile, Soubeyrand, Benoît, Baudin, MartineVolume:
31
Language:
english
Journal:
Vaccine
DOI:
10.1016/j.vaccine.2012.12.081
Date:
March, 2013
File:
PDF, 420 KB
english, 2013